Malezija - engleski - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novo nordisk pharma (malaysia) sdn. bhd. - liraglutide -

Europska Unija - engleski - EMA (European Medicines Agency)

novo nordisk a/s - insulin degludec, liraglutide - diabetes mellitus, type 2 - drugs used in diabetes - xultophy is indicated for the treatment of adults with type-2 diabetes mellitus to improve glycaemic control in combination with oral glucose-lowering medicinal products when these alone or combined with a glp-1 receptor agonist or basal insulin do not provide adequate glycaemic control.

Izrael - engleski - Ministry of Health

novo nordisk ltd., israel - insulin degludec; liraglutide - solution for injection - insulin degludec 100 u/ml; liraglutide 3.6 mg/ml - insulin degludec and liraglutide - xultophy® is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to other oral medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control, and the population studied, see sections 4.4, 4.5 and 5.1

Australija - engleski - Department of Health (Therapeutic Goods Administration)

novo nordisk pharmaceuticals pty ltd - insulin degludec, quantity: 100 u/ml; liraglutide, quantity: 3.6 u/ml - solution - excipient ingredients: phenol; zinc; glycerol; water for injections; sodium hydroxide; hydrochloric acid - xultophy is indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes mellitus to improve glycaemic control in combination with metformin, with or without other oral glucose-lowering medicinal products (see section 5.1 pharmacodynamic properties-clinical trials and section 4.4 special warnings and precautions for use? for available data on the different combinations).

Kenija - engleski - Pharmacy and Poisons Board

semaglutide - injection - 1.34 mg/ml - semaglutide

Singapur - engleski - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - semaglutide - tablet - semaglutide 14mg

Singapur - engleski - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - semaglutide - tablet - semaglutide 3mg

Singapur - engleski - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - semaglutide - tablet - semaglutide 7mg

Singapur - engleski - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - semaglutide - injection, solution - semaglutide 0.25mg/0.5ml

Singapur - engleski - HSA (Health Sciences Authority)

novo nordisk pharma (singapore) pte ltd - semaglutide - injection, solution - semaglutide 0.5mg/0.5ml